Taleen Hanania - Publications

PsychoGenics Inc, Tarrytown, NY, United States 
CNS disorders

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Shao L, Campbell UC, Fang QK, Powell NA, Campbell JE, Jones PG, Hanania T, Alexandrov V, Morganstern I, Sabath E, Zhong HM, Large TH, Spear KL. In vivo phenotypic drug discovery: Applying a behavioral assay to the discovery and optimization of novel antipsychotic agents Medchemcomm. 7: 1093-1101. DOI: 10.1039/c6md00128a  1
2015 Brunner D, Kabitzke P, He D, Cox K, Thiede L, Hanania T, Sabath E, Alexandrov V, Saxe M, Peles E, Mills A, Spooren W, Ghosh A, Feliciano P, Benedetti M, et al. Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder. Plos One. 10: e0134572. PMID 26273832 DOI: 10.1371/journal.pone.0134572  1
2015 Alexandrov V, Brunner D, Hanania T, Leahy E. Reprint of: Highthroughtput analysis of behavior for drug discovery. European Journal of Pharmacology. 753: 127-34. PMID 25744878 DOI: 10.1016/j.ejphar.2015.02.037  1
2015 Alexandrov V, Brunner D, Hanania T, Leahy E. High-throughput analysis of behavior for drug discovery. European Journal of Pharmacology. 750: 82-9. PMID 25592319 DOI: 10.1016/j.ejphar.2014.11.047  1
2015 Chang Q, Hanania T, Mash DC, Maillet EL. Noribogaine reduces nicotine self-administration in rats Journal of Psychopharmacology. 29: 704-711. DOI: 10.1177/0269881115584461  1
2013 Hanson JE, La H, Plise E, Chen YH, Ding X, Hanania T, Sabath EV, Alexandrov V, Brunner D, Leahy E, Steiner P, Liu L, Scearce-Levie K, Zhou Q. SAHA enhances synaptic function and plasticity in vitro but has limited brain availability in vivo and does not impact cognition. Plos One. 8: e69964. PMID 23922875 DOI: 10.1371/journal.pone.0069964  1
2013 Zhang HK, Yu LF, Eaton JB, Whiteaker P, Onajole OK, Hanania T, Brunner D, Lukas RJ, Kozikowski AP. Chemistry, pharmacology, and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile. Part II. Journal of Medicinal Chemistry. 56: 5495-504. PMID 23734673 DOI: 10.1021/jm400510u  1
2013 Gunosewoyo H, Midzak A, Gaisina IN, Sabath EV, Fedolak A, Hanania T, Brunner D, Papadopoulos V, Kozikowski AP. Characterization of maleimide-based glycogen synthase kinase-3 (GSK-3) inhibitors as stimulators of steroidogenesis. Journal of Medicinal Chemistry. 56: 5115-29. PMID 23725591 DOI: 10.1021/jm400511s  1
2012 Yu LF, Eaton JB, Fedolak A, Zhang HK, Hanania T, Brunner D, Lukas RJ, Kozikowski AP. Discovery of highly potent and selective α4β2-nicotinic acetylcholine receptor (nAChR) partial agonists containing an isoxazolylpyridine ether scaffold that demonstrate antidepressant-like activity. Part II. Journal of Medicinal Chemistry. 55: 9998-10009. PMID 23092294 DOI: 10.1021/jm301177j  1
2012 Zhang HK, Eaton JB, Yu LF, Nys M, Mazzolari A, van Elk R, Smit AB, Alexandrov V, Hanania T, Sabath E, Fedolak A, Brunner D, Lukas RJ, Vistoli G, Ulens C, et al. Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligands. Journal of Medicinal Chemistry. 55: 8028-37. PMID 22928944 DOI: 10.1021/jm3008739  1
2012 Saenger S, Holtmann B, Nilges MR, Schroeder S, Hoeflich A, Kletzl H, Spooren W, Ostrowitzki S, Hanania T, Sendtner M, Metzger F. Functional improvement in mouse models of familial amyotrophic lateral sclerosis by PEGylated insulin-like growth factor I treatment depends on disease severity. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 13: 418-29. PMID 22871074 DOI: 10.3109/17482968.2012.679944  1
2012 Yu LF, Tückmantel W, Eaton JB, Caldarone B, Fedolak A, Hanania T, Brunner D, Lukas RJ, Kozikowski AP. Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity. Journal of Medicinal Chemistry. 55: 812-23. PMID 22148173 DOI: 10.1021/jm201301h  1
2012 Paterson NE, Wetzler C, Hackett A, Hanania T. Impulsive action and impulsive choice are mediated by distinct neuropharmacological substrates in rat. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1473-87. PMID 22094071 DOI: 10.1017/S1461145711001635  1
2012 Brunner D, Alexandrov V, Caldarone B, Hanania T, Lowe D, Schneider J, Chandrasekhar J. Behavior-Based Screening as an Approach to Polypharmacological Ligands Polypharmacology in Drug Discovery. 303-313. DOI: 10.1002/9781118098141.ch14  1
2011 Roberds SL, Filippov I, Alexandrov V, Hanania T, Brunner D. Rapid, computer vision-enabled murine screening system identifies neuropharmacological potential of two new mechanisms. Frontiers in Neuroscience. 5: 103. PMID 21927596 DOI: 10.3389/fnins.2011.00103  1
2011 Vinkers CH, Olivier B, Hanania T, Min W, Schreiber R, Hopkins SC, Campbell U, Paterson N. Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem. European Journal of Pharmacology. 668: 190-3. PMID 21762686 DOI: 10.1016/j.ejphar.2011.06.054  1
2011 Chen W, Gaisina IN, Gunosewoyo H, Malekiani SA, Hanania T, Kozikowski AP. Structure-guided design of a highly selective glycogen synthase kinase-3β inhibitor: a superior neuroprotective pyrazolone showing antimania effects. Chemmedchem. 6: 1587-92. PMID 21751402 DOI: 10.1002/cmdc.201100231  1
2011 Caldarone BJ, Wang D, Paterson NE, Manzano M, Fedolak A, Cavino K, Kwan M, Hanania T, Chellappan SK, Kozikowski AP, Olivier B, Picciotto MR, Ghavami A. Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380. Psychopharmacology. 217: 199-210. PMID 21487659 DOI: 10.1007/s00213-011-2271-y  1
2011 Paterson NE, Ricciardi J, Wetzler C, Hanania T. Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone. Neuroscience Research. 69: 41-50. PMID 20934466 DOI: 10.1016/j.neures.2010.10.001  1
2011 Paterson NE, Balci F, Campbell U, Olivier BE, Hanania T. The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition. Journal of Psychopharmacology (Oxford, England). 25: 1357-64. PMID 20305042 DOI: 10.1177/0269881110364272  1
2010 Paterson NE, Min W, Hackett A, Lowe D, Hanania T, Caldarone B, Ghavami A. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 34: 1455-64. PMID 20708056 DOI: 10.1016/j.pnpbp.2010.07.037  1
2010 Paterson NE, Fedolak A, Olivier B, Hanania T, Ghavami A, Caldarone B. Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents. Pharmacology, Biochemistry, and Behavior. 95: 449-56. PMID 20346966 DOI: 10.1016/j.pbb.2010.03.006  1
2010 Paterson NE, Iwunze M, Davis SF, Malekiani SA, Hanania T. Comparison of the predictive validity of the mirror chamber and elevated plus maze tests in mice. Journal of Neuroscience Methods. 188: 62-70. PMID 20149823 DOI: 10.1016/j.jneumeth.2010.02.005  1
2010 Paterson NE, Hanania T. The modified Geller-Seifter test in rats was insensitive to GABAB receptor positive modulation or blockade, or 5-HT1A receptor activation. Behavioural Brain Research. 208: 258-64. PMID 20006648 DOI: 10.1016/j.bbr.2009.12.006  1
2009 Paterson NE, Malekiani SA, Foreman MM, Olivier B, Hanania T. Pharmacological characterization of harmaline-induced tremor activity in mice. European Journal of Pharmacology. 616: 73-80. PMID 19497322 DOI: 10.1016/j.ejphar.2009.05.031  1
2009 Foreman MM, Hanania T, Eller M. Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test. European Journal of Pharmacology. 602: 316-20. PMID 19038245 DOI: 10.1016/j.ejphar.2008.11.013  1
2008 Breuer ME, Chan JS, Oosting RS, Groenink L, Korte SM, Campbell U, Schreiber R, Hanania T, Snoeren EM, Waldinger M, Olivier B. The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: 908-16. PMID 18789657 DOI: 10.1016/j.euroneuro.2008.07.011  1
2008 Vinkers CH, van Bogaert MJ, Klanker M, Korte SM, Oosting R, Hanania T, Hopkins SC, Olivier B, Groenink L. Translational aspects of pharmacological research into anxiety disorders: the stress-induced hyperthermia (SIH) paradigm. European Journal of Pharmacology. 585: 407-25. PMID 18420191 DOI: 10.1016/j.ejphar.2008.02.097  1
2008 Foreman MM, Hanania T, Stratton SC, Wilcox KS, White HS, Stables JP, Eller M. In vivo pharmacological effects of JZP-4, a novel anticonvulsant, in models for anticonvulsant, antimania and antidepressant activity. Pharmacology, Biochemistry, and Behavior. 89: 523-34. PMID 18377968 DOI: 10.1016/j.pbb.2008.02.007  1
2004 Hanania T, McCreary AC, Salaz DO, Lyons AM, Zahniser NR. Differential regulation of cocaine-induced locomotor activity in inbred long-sleep and short-sleep mice by dopamine and serotonin systems. European Journal of Pharmacology. 502: 221-31. PMID 15476748 DOI: 10.1016/j.ejphar.2004.09.001  1
2004 Hanania T, Gulley JM, Salaz DO, Larson GA, Zahniser NR. Role of the dopamine transporter in the differential cocaine-induced locomotor activation of inbred long-sleep and short-sleep mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1814-22. PMID 15199369 DOI: 10.1038/sj.npp.1300501  1
2002 Hanania T, McCreary AC, Haughey HM, Salaz DO, Zahniser NR. MK-801- and ethanol-induced activity in inbred long-sleep and short-sleep mice: dopamine and serotonin systems. European Journal of Pharmacology. 457: 125-35. PMID 12464358 DOI: 10.1016/S0014-2999(02)02685-7  1
2002 Hanania T, Zahniser NR. Locomotor activity induced by noncompetitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice. Alcoholism, Clinical and Experimental Research. 26: 431-40. PMID 11981117  1
2000 Hanania T, Negri CA, Dunwiddie TV, Zahniser NR. N-methyl-D-aspartate receptor responses are differentially modulated by noncompetitive receptor antagonists and ethanol in inbred long-sleep and short-sleep mice: behavior and electrophysiology. Alcoholism, Clinical and Experimental Research. 24: 1750-8. PMID 11141032  1
2000 Zahniser NR, Simosky JK, Mayfield RD, Negri CA, Hanania T, Larson GA, Kelly MA, Grandy DK, Rubinstein M, Low MJ, Fredholm BB. Functional uncoupling of adenosine A(2A) receptors and reduced responseto caffeine in mice lacking dopamine D2 receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 5949-57. PMID 10934242  1
1999 Zahniser NR, Negri CA, Hanania T, Gehle VM. MK-801-induced locomotor activity in long-sleep x short-sleep recombinant inbred mouse strains: correlational analysis with low-dose ethanol and provisional quantitative trait loci. Alcoholism, Clinical and Experimental Research. 23: 1721-9. PMID 10591587  1
1999 Hanania T, Johnson KM. Regulation of NMDA-stimulated [14C]GABA and [3H]acetylcholine release by striatal glutamate and dopamine receptors. Brain Research. 844: 106-17. PMID 10536266 DOI: 10.1016/S0006-8993(99)01869-7  1
1999 Hanania T, Hillman GR, Johnson KM. Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit. Synapse (New York, N.Y.). 31: 229-39. PMID 10029241 DOI: 10.1002/(SICI)1098-2396(19990301)31:3<229::AID-SYN8>3.0.CO;2-3  1
1998 Hanania T, Johnson KM. Regulation of neurotransmitter release by endogenous nitric oxide in striatal slices. European Journal of Pharmacology. 359: 111-7. PMID 9832380 DOI: 10.1016/S0014-2999(98)00636-0  1
Show low-probability matches.